Extracellular vesicles in the biology of brain tumour stem cells - Implications for inter-cellular communication, therapy and biomarker development

Seminars in Cell and Developmental Biology

Volumn 40, Issue , 2015, Pages 17-26

  Nakano, Ichiro ^a   Garnier, Delphine ^b   Minata, Mutsuko ^a   Rak, Janusz ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Cancer; Exosomes; Extracellular vesicles; Glioblastoma; Glioma stem cells; Oncogenes

Indexed keywords

DNA; MICRORNA; BIOLOGICAL MARKER;

BRAIN TUMOR; CANCER STEM CELL; CARCINOGENESIS; CELL COMMUNICATION; EPIGENETICS; EXOSOME; GLIOBLASTOMA; GLIOMA STEM CELL; HUMAN; REVIEW; STEM CELL NICHE; STRESS; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN NEOPLASMS; CHEMISTRY; DRUG EFFECTS; METABOLISM; PATHOLOGY;

ANIMALS; BIOMARKERS; BRAIN NEOPLASMS; CELL COMMUNICATION; EXTRACELLULAR VESICLES; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS;

EID: 84929285231     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2015.02.011     Document Type: Review

References (155)

1. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
2. Balaj L., Lessard R., Dai L., Cho Y.J., Pomeroy S.L., Breakefield X.O., et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2011, 2:180.
3. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Sena-Esteves M., Curry W.T., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476.
4. van der Vos K.E., Balaj L., Skog J., Breakefield X.O. Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol 2011, 31:949-959.
5. Lee T.-H., Montermini L., Meehan B., Magnus N., Garnier D., Rak J. Collateral cell transformation by exosome-like extracellular vesicles harbouring mutant H-ras oncogene. J Extracell Vesicles 2013, (ISEV 2013 - Meeting Abstracts).
6. Lee T.H., Chennakrishnaiah S., Audemard E., Montermini L., Meehan B., Rak J. Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells. Biochem Biophys Res Commun 2014, 451:295-301.
7. Thakur B.K., Zhang H., Becker A., Matei I., Huang Y., Costa-Silva B., et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 2014, 24:766-769.
8. Kahlert C., Melo S.A., Protopopov A., Tang J., Seth S., Koch M., et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 2014, 289:3869-3875.
9. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2011.
10. Guescini M., Genedani S., Stocchi V., Agnati L.F. Astrocytes and glioblastoma cells release exosomes carrying mtDNA. J Neural Transm 2010, 117:1-4.
11. Trams E.G., Lauter C.J., Salem N., Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 1981, 645:63-70.
12. Greco V., Hannus M., Eaton S. Argosomes: a potential vehicle for the spread of morphogens through epithelia. Cell 2001, 106:633-645.
13. Stegmayr B., Ronquist G. Promotive effect on human sperm progressive motility by prostasomes. Urol Res 1982, 10:253-257.
14. Marzesco A.M. Prominin-1-containing membrane vesicles: origins, formation, and utility. Adv Exp Med Biol 2013, 777:41-54.
15. Al-Nedawi K., Meehan B., Micallef J., Lhotak V., May L., Guha A., et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008, 10:619-624.
16. Di Vizio D., Kim J., Hager M.H., Morello M., Yang W., Lafargue C.J., et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 2009, 69:5601-5609.
17. Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., Ratajczak M.Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20:1487-1495.
18. Bobrie A., Thery C. Exosomes and communication between tumours and the immune system: are all exosomes equal. Biochem Soc Trans 2013, 41:263-267.
19. Garnier D., Magnus N., Lee T.H., Bentley V., Meehan B., Milsom C., et al. Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J Biol Chem 2012, 287:43565-43572.
20. Gould S.J., Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles 2013, 2:10.
21. Kalra H., Simpson R.J., Ji H., Aikawa E., Altevogt P., Askenase P., et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012, 10:e1001450.
22. Garnier D., Magnus N., Meehan B., Kislinger T., Rak J. Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Exp Cell Res 2013, 10.
23. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319:1244-1247.
24. Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009, 9:40-55.
25. Souza-Schorey C., Clancy J.W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012, 26:1287-1299.
26. Li B., Antonyak M.A., Zhang J., Cerione R.A. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 2012, 10.
27. Muralidharan-Chari V., Clancy J., Plou C., Romao M., Chavrier P., Raposo G., et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 2009, 19:1875-1885.
28. Piccin A., Murphy W.G., Smith O.P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007, 21:157-171.
29. Gyorgy B., Szabo T.G., Pasztoi M., Pal Z., Misják P., Aradi B., et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011, 68:2667-2688.
30. Bolukbasi M.F., Mizrak A., Ozdener G.B., Madlener S., Ströbel T., Erkan E.P., et al. miR-1289 and Zipcode-like Sequence Enrich mRNAs in microvesicles. Mol Ther Nucleic Acids 2012, 1:e10.
31. Gibbings D.J., Ciaudo C., Erhardt M., Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 2009, 11:1143-1149.
32. Belting M., Wittrup A. Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease. J Cell Biol 2008, 183:1187-1191.
33. Bianco F., Perrotta C., Novellino L., Francolini M., Riganti L., Menna E., et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J 2009, 28:1043-1054.
34. Taraboletti G., D'Ascenzo S., Giusti I., Marchetti D., Borsotti P., Millimaggi D., et al. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 2006, 8:96-103.
35. Sheldon H., Heikamp E., Turley H., Dragovic R., Thomas P., Oon C.E., et al. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 2010, 116:2385-2394.
36. Mulcahy L.A., Pink R.C., Carter D.R. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 2014, 3:10.
37. Del Conde I., Shrimpton C.N., Thiagarajan P., Lopez J.A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005, 106:1604-1611.
38. Fitzner D., Schnaars M., van Rossum D., Krishnamoorthy G., Dibaj P., Bakhti M., et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci 2011, 124:447-458.
39. Atai N.A., Balaj L., van Veen H., Breakefield X.O., Jarzyna P.A., Van Noorden C.J., et al. Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J Neurooncol 2013, 115:343-351.
40. Svensson K.J., Christianson H.C., Wittrup A., Bourseau-Guilmain E., Lindqvist E., Svensson L.M., et al. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem 2013, 288:17713-17724.
41. Harding C., Heuser J., Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 1983, 97:329-339.
42. Pan B.T., Johnstone R.M. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 1983, 33:967-978.
43. Chairoungdua A., Smith D.L., Pochard P., Hull M., Caplan M.J. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 2010, 20(190):1079-1091.
44. Verweij F.J., van Eijndhoven M.A., Hopmans E.S., Vendrig T., Wurdinger T., Cahir-McFarland E., et al. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-kappaB activation. EMBO J 2011, 30:2115-2129.
45. Putz U., Howitt J., Doan A., Goh C.P., Low L.H., Silke J., et al. The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal 2012, 5:ra70.
46. Gabriel K., Ingram A., Austin R., Kapoor A., Tang D., Majeed F., et al. Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer. PLOS ONE 2013, 8:e70047.
47. Rak J. Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol 2013, 4:21. (Epub 06.03.13).
48. Jella K.K., Rani S., O'Driscoll L., McClean B., Byrne H.J., Lyng F.M. Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells. Radiat Res 2014, 181:138-145.
49. Bebawy M., Combes V., Lee E., Jaiswal R., Gong J., Bonhoure A., et al. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 2009, 23:1643-1649.
50. Yu J.L., May L., Lhotak V., Shahrzad S., Shirasawa S., Weitz J.I., et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 2005, 105:1734-1741.
51. Yu X., Harris S.L., Levine A.J. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 2006, 66:4795-4801.
52. Lespagnol A., Duflaut D., Beekman C., Blanc L., Fiucci G., Marine J.C., et al. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ 2008, 15:1723-1733.
53. Peinado H., Aleckovic M., Lavotshkin S., Matei I., Costa-Silva B., Moreno-Bueno G., et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012, 18:833-891.
54. Al-Nedawi K., Meehan B., Kerbel R.S., Allison A.C., Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 2009, 106:3794-3799.
55. Demory Beckler M., Higginbotham J.N., Franklin J.L., Ham A.J., Halvey P.J., Imasuen I.E., et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteom 2013, 12:343-355.
56. Atay S., Banskota S., Crow J., Sethi G., Rink L., Godwin A.K. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc Natl Acad Sci U S A 2014, 111:711-716.
57. Chen C., Skog J., Hsu C.H., Lessard R.T., Balaj L., Wurdinger T., et al. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 2010, 10:505-511.
58. Holmgren L., Szeles A., Rajnavolgyi E., Folkman J., Klein G., Ernberg I., et al. Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 1999, 93:3956-3963.
59. Antonyak M.A., Li B., Boroughs L.K., Johnson J.L., Druso J.E., Bryant K.L., et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci U S A 2011, 108:4852-4857.
60. Lim J.W., Mathias R.A., Kapp E.A., Layton M.J., Faux M.C., Burgess A.W., et al. Restoration of full-length APC protein in SW480 colon cancer cells induces exosome-mediated secretion of DKK-4. Electrophoresis 2012, 33:1873-1880.
61. Janowska-Wieczorek A., Marquez-Curtis L.A., Wysoczynski M., Ratajczak M.Z. Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion (Paris) 2006, 46:1199-1209.
62. Luga V., Zhang L., Viloria-Petit A.M., Ogunjimi A.A., Inanlou M.R., Chiu E., et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012, 151:1542-1556.
63. Shimoda M., Principe S., Jackson H.W., Luga V., Fang H., Molyneux S.D., et al. Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state. Nat Cell Biol 2014, 10.
64. Roccaro A.M., Sacco A., Maiso P., Azab A.K., Tai Y.T., Reagan M., et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 2013, 123:1542-1555.
65. Koch R., Demant M., Aung T., Diering N., Cicholas A., Chapuy B., et al. Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma. Blood 2014, 123:2189-2198.
66. Corrado C., Raimondo S., Saieva L., Flugy A.M., De Leo G., Alessandro R. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. Cancer Lett 2014, 348:71-76.
67. Ono M., Kosaka N., Tominaga N., Yoshioka Y., Takeshita F., Takahashi R.U., et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal 2014, 7:ra63.
68. Yan T., Mizutani A., Chen L., Takaki M., Hiramoto Y., Matsuda S., et al. Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles. J Cancer 2014, 5:572-584.
69. Abd Elmageed Z.Y., Yang Y., Thomas R., Ranjan M., Mondal D., Moroz K., et al. Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes. Stem Cells 2014, 32:983-997.
70. Bronisz A., Wang Y., Nowicki M.O., Peruzzi P., Ansari K.I., Ogawa D., et al. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res 2014, 74:738-750.
71. Katakowski M., Buller B., Zheng X., Lu Y., Rogers T., Osobamiro O., et al. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett 2013, 335:201-204.
72. Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012, 366:883-892.
73. Dick J.E. Looking ahead in cancer stem cell research. Nat Biotechnol 2009, 27:44-46.
74. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
75. Friedmann-Morvinski D., Bushong E.A., Ke E., Soda Y., Marumoto T., Singer O., et al. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 2012, 338:1080-1084.
76. Ghajar C.M., Peinado H., Mori H., Matei I.R., Evason K.J., Brazier H., et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 2013, 15:807-817.
77. Magnus N., Garnier D., Meehan B., McGraw S., Lee T.H., Caron M., et al. Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations. Proc Natl Acad Sci U S A 2014, 111:3544-3549.
78. Finak G., Bertos N., Pepin F., Sadekova S., Souleimanova M., Zhao H., et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008, 14:518-527.
79. Ratajczak J., Miekus K., Kucia M., Zhang J., Reca R., Dvorak P., et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006, 20:847-856.
80. Tauro B.J., Mathias R.A., Greening D.W., Gopal S.K., Ji H., Kapp E.A., et al. Oncogenic H-Ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition. Mol Cell Proteom 2013.
81. Kucharzewska P., Christianson H.C., Welch J.E., Svensson K.J., Fredlund E., Ringnér M., et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A 2013, 110:7312-7317.
82. Svensson K.J., Kucharzewska P., Christianson H.C., Skold S., Löfstedt T., Johansson M.C., et al. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci U S A 2011, 108:13147-13152.
83. Tadokoro H., Umezu T., Ohyashiki K., Hirano T., Ohyashiki J.H. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem 2013, 288:34343-34351.
84. Aga M., Bentz G.L., Raffa S., Torrisi M.R., Kondo S., Wakisaka N., et al. Exosomal HIF1alpha supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes. Oncogene 2014, 10.
85. Ghosh A.K., Secreto C.R., Knox T.R., Ding W., Mukhopadhyay D., Kay N.E. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 2010, 115:1755-1764.
86. Andaloussi S.E.L., Mager I., Breakefield X.O., Wood M.J. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013, 12:347-357.
87. Quesenberry P.J., Dooner M.S., Aliotta J.M. Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles. Exp Hematol 2010, 38:581-592.
88. Poste G., Nicolson G.L. Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci U S A 1980, 77:399-403.
89. Janowska-Wieczorek A., Wysoczynski M., Kijowski J., Marquez-Curtis L., Machalinski B., Ratajczak J., et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005, 113:752-760.
90. Hao S., Ye Z., Li F., Meng Q., Qureshi M., Yang J., et al. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. Exp Oncol 2006, 28:126-131.
91. Jung T., Castellana D., Klingbeil P., Cuesta Hernandez I., Vitacolonna M., Orlicky D.J., et al. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 2009, 11:1093-1105.
92. Hood J.L., San R.S., Wickline S.A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 2011, 71:3792-3801.
93. Hendrix A., Westbroek W., Bracke M., De Wever O. An ex(o)citing machinery for invasive tumor growth. Cancer Res 2010, 70:9533-9537.
94. Choi D.S., Choi D.Y., Hong B.S., Jang S.C., Kim D.K., Lee J., et al. Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells. J Extracell Vesicles 2012, 1:10.
95. Ji H., Greening D.W., Barnes T.W., Lim J.W., Tauro B.J., Rai A., et al. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 2013, 13:1672-1686.
96. Papi A., De Carolis S., Bertoni S., Storci G., Sceberras V., Santini D., et al. PPARgamma and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche. J Cell Physiol 2014, 229:1595-1606.
97. Grange C., Tapparo M., Collino F., Vitillo L., Damasco C., Deregibus M.C., et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 2011, 71:5346-5356.
98. Lee J.K., Park S.R., Jung B.K., Jeon Y.K., Lee Y.S., Kim M.K., et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLOS ONE 2013, 8:e84256.
99. Gross J.C., Chaudhary V., Bartscherer K., Boutros M. Active Wnt proteins are secreted on exosomes. Nat Cell Biol 2012, 14:1036-1045.
100. Wen P.Y., Kesari S. Malignant gliomas in adults. N Engl J Med 2008, 359:492-507.
101. Kaper F., Dornhoefer N., Giaccia A.J. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions. Cancer Res 2006, 66:1561-1569.
102. Goodwin C.R., Lal B., Ho S., Woodard C.L., Zhou X., Taeger A., et al. PTEN reconstitution alters glioma responses to c-Met pathway inhibition. Anticancer Drugs 2011, 22:905-912.
103. Chaichana K.L., McGirt M.J., Laterra J., Olivi A., Quiñones-Hinojosa A. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg 2010, 112:10-17.
104. Omuro A., DeAngelis L.M. Glioblastoma and other malignant gliomas: a clinical review. J Am Med Assoc 2013, 310:1842-1850.
105. Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10:459-466.
106. Locatelli M., Ferrero S., Martinelli Boneschi F., Boiocchi L., Zavanone M., Maria Gaini S., et al. The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas. J Neuroimmunol 2013, 260:99-106.
107. Oh M.C., Kim J.M., Safaee M., Kaur G., Sun M.Z., Kaur R., et al. Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells. PLoS ONE 2012, 7:e47846.
108. Tafani M., Di Vito M., Frati A., Pellegrini L., De Santis E., Sette G., et al. Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma. J Neuroinflamm 2011, 8:32-38.
109. Candolfi M., King G.D., Yagiz K., Curtin J.F., Mineharu Y., Muhammad A.K., et al. Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics. Neoplasia 2012, 14:757-770.
110. Lei L., Sonabend A.M., Guarnieri P., Soderquist C., Ludwig T., Rosenfeld S., et al. Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PLoS ONE 2011, 6:e20041.
111. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 19(17):98-110.
112. Phillips H.S., Kharbanda S., Chen R., Forrest W.F., Soriano R.H., Wu T.D., et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006, 9:157-173.
113. Ohgaki H., Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res 2013, 19:764-772.
114. Mischel P.S., Shai R., Shi T., Horvath S., Lu K.V., Choe G., et al. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 2003, 22:2361-2373.
115. Lasky J.L., Choe M., Nakano I. Cancer stem cells in pediatric brain tumors. Curr Stem Cell Res Ther 2009, 4:298-305.
116. Huang Z., Cheng L., Guryanova O.A., Wu Q., Bao S. Cancer stem cells in glioblastoma - molecular signaling and therapeutic targeting. Protein Cell 2010, 1:638-655.
117. Patel A.P., Tirosh I., Trombetta J.J., Shalek A.K., Gillespie S.M., Wakimoto H., et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014, 344:1396-1401.
118. Suva M.L., Rheinbay E., Gillespie S.M., Patel A.P., Wakimoto H., Rabkin S.D., et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 2014, 157:580-594.
119. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
120. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
121. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
122. Capper D., Gaiser T., Hartmann C., Habel A., Mueller W., Herold-Mende C., et al. Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation. Acta Neuropathol 2009, 117:445-456.
123. Beier D., Schulz J.B., Beier C.P. Chemoresistance of glioblastoma cancer stem cells - much more complex than expected. Mol Cancer 2011, 10:128-139.
124. Vescovi A.L., Galli R., Reynolds B.A. Brain tumour stem cells. Nat Rev Cancer 2006, 6:425-436.
125. Bhat K.P., Balasubramaniyan V., Vaillant B., Ezhilarasan R., Hummelink K., Hollingsworth F., et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 2013, 24:331-346.
126. Mao P., Joshi K., Li J., Kim S.H., Li P., Santana-Santos L., et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci U S A 2013, 110:8644-8649.
127. Carro M.S., Lim W.K., Alvarez M.J., Bollo R.J., Zhao X., Snyder E.Y., et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010, 463:318-325.
128. Shirkoohi R. Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance. Cancer Sci 2013, 104:28-35.
129. Nurwidya F., Takahashi F., Murakami A., Takahashi K. Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer. Cancer Res Treat 2012, 44:151-156.
130. Sanchez-Tillo E., Liu Y., de Barrios O., Siles L., Fanlo L., Cuatrecasas M., et al. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 2012, 69:3429-3456.
131. Halliday J., Helmy K., Pattwell S.S., Pitter K.L., LaPlant Q., Ozawa T., et al. In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift. Proc Natl Acad Sci U S A 2014, 111:5248-5253.
132. Ozawa T., Riester M., Cheng Y.K., Huse J.T., Squatrito M., Helmy K., et al. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell 2014, 26:288-300.
133. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
134. Lu K.V., Chang J.P., Parachoniak C.A., Pandika M.M., Aghi M.K., Meyronet D., et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 2012, 22:21-35.
135. Sharma S., Das K., Woo J., Gimzewski J.K. Nanofilaments on glioblastoma exosomes revealed by peak force microscopy. J R Soc Interface 2014, 11:20131150.
136. Garnier D., Jabado N., Rak J. Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours. Proteomics 2013, 13:1595-1607.
137. Putz U., Doan A., Tan S.-S. The tumor suppressor PTEN is transported in exosomes for extracellular phosphatase activity. J Extracell Vesicles 2012, 1:78.
138. Schiera G., Di Liegro C.M., Saladino P., Pitti R., Savettieri G., Proia P., et al. Oligodendroglioma cells synthesize the differentiation-specific linker histone H1 and release it into the extracellular environment through shed vesicles. Int J Oncol 2013, 43:1771-1776.
139. Li C.C., Eaton S.A., Young P.E., Lee M., Shuttleworth R., Humphreys D.T., et al. Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol 2013, 10:1333-1344.
140. Arscott W.T., Tandle A.T., Zhao S., Shabason J.E., Gordon I.K., Schlaff C.D., et al. Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. Transl Oncol 2013, 6:638-648.
141. Sartori M.T., Della Puppa A., Ballin A., Saggiorato G., Bernardi D., Padoan A., et al. Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J Neurooncol 2011, 104:225-231.
142. Liu Z.M., Wang Y.B., Yuan X.H. Exosomes from murine-derived GL26 cells promote glioblastoma tumor growth by reducing number and function of CD8+ T cells. Asian Pac J Cancer Prev 2013, 14:309-314.
143. Redzic J.S., Ung T.H., Graner M.W. Glioblastoma extracellular vesicles: reservoirs of potential biomarkers. Pharmgenomics Pers Med 2014, 7:65-77.
144. Inda M.M., Bonavia R., Mukasa A., Narita Y., Sah D.W., Vandenberg S., et al. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev 2010, 24:1731-1745.
145. Biernat W., Huang H., Yokoo H., Kleihues P., Ohgaki H. Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas. Brain Pathol 2004, 14:131-136.
146. Chittiboina P., Connor D.E., Caldito G., Quillin J.W., Wilson J.D., Nanda A. Occult tumors presenting with negative imaging: analysis of the literature. J Neurosurg 2012, 116:1195-1203.
147. Hochberg F., Toniolo P., Cole P. Head trauma and seizures as risk factors of glioblastoma. Neurology 1984, 34:1511-1514.
148. Black W.C., Welch H.G. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 1993, 328:1237-1243.
149. Rak J. Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis. Med Hypotheses 2006, 66:601-604.
150. Akers J.C., Ramakrishnan V., Kim R., Skog J., Nakano I., Pingle S., et al. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLOS ONE 2013, 8:e78115.
151. Hochberg F.H., Atai N.A., Gonda D., Hughes M.S., Mawejje B., Balaj L., et al. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science. Expert Rev Mol Diagn 2014, 14:439-452.
152. Zhu Z., Khan M.A., Weiler M., Blaes J., Jestaedt L., Geibert M., et al. Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival. Cell Stem Cell 2014, 15:185-198.
153. Heppner G.H. Tumor cell societies. J Natl Cancer Inst 1989, 81:648-649.
154. Magnus N., Gerges N., Jabado N., Rak J. Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype. J Thromb Haemost 2013, 11:1197-1200.
155. D'Asti E., Kool M., Pfister S.M., Rak J. Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma - evidence for growth factor-thrombin cross-talk. J Thromb Haemost 2014, 10.